Testing a new way to treat PTSD in people with substance use issues
Hybrid Effectiveness-Implementation Trial of Massed PTSD Treatment in a Community Substance Use Program
This study is looking at a new way to help people with both PTSD and substance use issues by offering more therapy sessions each week, to see if this helps them feel better and stick with their treatment more than the usual once-a-week sessions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers, the State Univ of N.j. NIH-funded |
| Lab location | 1 site (Piscataway, United States) |
| Project ID | NIH-10953871 on NIH RePORTER |
What this research studies
This research investigates a treatment approach for individuals suffering from both posttraumatic stress disorder (PTSD) and substance use disorders (SUD). It focuses on a method called massed Prolonged Exposure (M-PE), which involves multiple therapy sessions each week, aiming to improve attendance and treatment outcomes. The study will be conducted in a community substance use program, where patients will receive this intensive therapy to address their PTSD symptoms alongside their substance use challenges. By comparing this approach to traditional weekly sessions, the research seeks to find more effective ways to help patients recover.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with both PTSD and substance use disorders who are seeking treatment.
Not a fit: Patients who do not have PTSD or substance use disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment outcomes for patients dealing with both PTSD and substance use disorders.
How similar studies have performed: Previous studies have shown that massed Prolonged Exposure therapy can be effective for PTSD, suggesting this approach may yield positive results for co-occurring disorders.
Where this research is happening
Piscataway, United States
- Rutgers, the State Univ of N.j. — Piscataway, United States (Active)
Researchers
- Principal investigator: Hien, Denise Aimee — Rutgers, the State Univ of N.j.
- Study coordinator: Hien, Denise Aimee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.